Literature DB >> 11089724

Psychotropic interactions with warfarin.

K S Sayal1, D A Duncan-McConnell, H W McConnell, D M Taylor.   

Abstract

OBJECTIVE: Improving knowledge about the cytochrome p450 system means that potential drug interactions can be predicted. Interactions involving warfarin may be thus avoidable. As many patients who have suffered from a stroke or other thromboembolic events may also develop psychiatric disorder, knowledge about possible interactions with psychotropics is essential for prescribers.
METHOD: A Medline and hand search of published literature was complemented by contacting manufacturers.
RESULTS: The antidepressants citalopram, nefazodone and sertraline have relatively low interaction potential with warfarin; fluoxetine and fluvoxamine relatively high. Carbamazepine appears to reduce warfarin's anticoagulant effect. Other antipsychotics, antidepressants and anxiolytics have only a theoretical risk of interaction. Lithium, gabapentin, sulpiride and amisulpride are predominantly renally excreted and so are not likely to interact with warfarin.
CONCLUSION: Many psychotropics are involved in predictable interactions with warfarin. Drugs with a known low interaction potential should be chosen instead of those known or predicted to interact.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089724     DOI: 10.1034/j.1600-0447.2000.102004250.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

Review 1.  Clinically significant drug interactions with newer antidepressants.

Authors:  Edoardo Spina; Gianluca Trifirò; Filippo Caraci
Journal:  CNS Drugs       Date:  2012-01-01       Impact factor: 5.749

Review 2.  Anticoagulation and psychotropic medications.

Authors:  Maurice Bachawati
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 3.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Pulmonary embolism as a complication of major depressive disorder with catatonic features: a case report.

Authors:  Michael Ignatowski; Santokh Sidhu; Marie Rueve
Journal:  Psychiatry (Edgmont)       Date:  2007-06

Review 5.  [SSRI - treatment and bleeding. What risks do we take?].

Authors:  T Strubel; A Birkhofer; G Mössmer; H Förstl
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

6.  Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.

Authors:  Xavier Vidal; Luisa Ibáñez; Lourdes Vendrell; Ana Conforti; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

7.  Risk of Stroke Among Older Medicare Antidepressant Users With Traumatic Brain Injury.

Authors:  Bilal Khokhar; Linda Simoni-Wastila; Jennifer S Albrecht
Journal:  J Head Trauma Rehabil       Date:  2017 Jan/Feb       Impact factor: 2.710

8.  Warfarin and Antidepressants: Happiness without Hemorrhaging.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-07

9.  Warfarin toxicity and individual variability-clinical case.

Authors:  Irina Piatkov; Colin Rochester; Trudi Jones; Steven Boyages
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

10.  Bupropion-warfarin combination: a serious complication.

Authors:  Amar D Bavle; Akshay S Phatak
Journal:  Indian J Psychol Med       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.